Vimarsana
Biggest News Aggregation in the World

Eper Spray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eper Spray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eper Spray Today - Breaking & Trending Today

Pepper Spray A Dangerous Weapon, Can't Be Used For Private Defense When There's No Imminent Threat Or Danger Caused To Life: Karnataka High Court - Vimarsana News

Pepper Spray A Dangerous Weapon, Can't Be Used For Private Defense When There's No Imminent Threat Or Danger Caused To Life: Karnataka High Court

The Karnataka High Court refused to quash a criminal case against C Ganesh Narayan, the Director of C.Krishniah Chetty & Company Private Limited and his wife accused of using pepper spray on the...

Source: livelaw.in
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor... | May 12, 2023

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Vimarsana News

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in Q4 vs. Q3 2022 to $5 Million Impel... | March 24, 2023

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update

15.08.2022 - Trudhesa TRx’s Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Range ...